BeStock  
Stocks › Gene Editing › BEAM

Beam Therapeutics BEAM

US equityMarket cap rank #2634AI medical concept stocksGene Editing
$20.90 −$0.04 (-0.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $21.66 +3.65%
Open$20.60
Prev close$20.94
Day range$20.54 – $22.10
Volume3.89M
Market cap$2.16B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership114.0%+1.81 pts vs. prior quarter
Institutions holding325-14 vs. prior quarter
Insider trades (recent)19 buys / 31 sellsNet selling
ARK fund activity+154,912 sh4 recent transactions · last 29 Oct 2026
Short interest25.25% of floatDays to cover 13.7 · as of 30 Oct 2026
Short-sale volume share31.8%5-day average of daily volume

Short-sale volume as % of daily volume

11%21%32%42%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$11.08M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$8.2MSuper−$2.9MBig−$548.5KMid+$3.1MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 49.3% of shares outstanding.

Largest holders

  • FMR12.11%
  • ARK Investment Management LLC11.84%
  • Farallon Capital Management, L.L.C.10.27%
  • BlackRock9.15%
  • State Street Global Advisors5.94%
  • Vanguard Portfolio Management, LLC4.92%
  • Vanguard Capital Management, LLC4.62%
  • Arch Venture Partners, L.P.4.56%

By investor type

  • Mutual Fund78.76%
  • Hedge Fund18.58%
  • VC/PE Fund9.59%
  • Public Company4.23%
  • Private Company1.88%
  • Individual/Insider1.36%
  • Government Pension Fund0.51%
  • Family Office/Trust0.25%

Reported short interest has risen from 23.60% to 25.25% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
ARK Investment Management LLC Mutual Fund 2026/Q3 +1,570,510 11.8%
Baillie Gifford Mutual Fund 2026/Q3 +508,732 0.8%
FMR Mutual Fund 2026/Q3 +317,877 12.1%
Peregrine Investment Management, Inc. Hedge Fund 2026/Q3 +239,030 0.3%
First Trust Advisors L.P. Mutual Fund 2026/Q3 +169,793 0.3%
Public Sector Pension Investment Board Government Pension Fund 2026/Q3 +154,000 0.2%
Edgestream Partners, L.P. Hedge Fund 2026/Q3 +148,556 0.2%
BlackRock Mutual Fund 2026/Q3 +121,555 9.1%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +116,163 0.2%
Morgan Stanley Public Company 2026/Q3 +1,186,149 1.7%
Contrarius Investment Management Ltd. Mutual Fund 2026/Q3 +1,081,095 1.6%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +702,009 3.4%
BlackRock Mutual Fund 2026/Q3 +509,973 9.0%
FMR Mutual Fund 2026/Q3 +441,216 11.8%
Jupiter Fund Management Plc Mutual Fund 2026/Q3 +421,658 0.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
15 Oct 2026 John Evans Chief Executive Officer Intent to Sell (Form 144) -25,000 $23.98 –
15 Oct 2026 John Evans Chief Executive Officer Derivative Exercise and Sale -50,000 $23.98 949,268
14 Oct 2026 John Evans Chief Executive Officer Intent to Sell (Form 144) -25,000 $23.57 –
30 Sep 2026 Bethany Cavanagh Senior VP of Finance, Treasurer & Principal Accounting Officer Automatic Disposition -187 $24.41 13,859
23 Sep 2026 Giuseppe Ciaramella President Other Disposition -123,407 – 165,161
26 Jul 2026 Amy Simon Chief Medical Officer Automatic Disposition -16,667 $25.74 2,071
29 Jun 2026 John Evans Chief Executive Officer Intent to Sell (Form 144) -25,000 $34.31 –
29 Jun 2026 Amy Simon Chief Medical Officer Automatic Disposition -373 $34.73 18,738
29 Jun 2026 John Evans Chief Executive Officer Derivative Exercise and Sale -50,000 $35.91 949,267
28 Jun 2026 John Evans Chief Executive Officer Intent to Sell (Form 144) -25,000 $35.49 –
16 Jun 2026 Giuseppe Ciaramella President Derivative Exercise and Retained +35,505 $1.03 165,161
2 Jun 2026 John Michael Maraganore Independent Director Other Derivative Acquisition +19,676 $29.55 19,676
2 Jun 2026 Mark Fishman Lead Independent Director Other Derivative Acquisition +19,676 $29.55 19,676
2 Jun 2026 Graham Cooper Independent Director Other Derivative Acquisition +19,676 $29.55 19,676
2 Jun 2026 Kathleen Walsh Independent Director Other Derivative Acquisition +19,676 $29.55 19,676
2 Jun 2026 Chirfi Guindo Independent Director Other Derivative Acquisition +19,676 $29.55 19,676
2 Jun 2026 Christi Shaw Independent Director Other Derivative Acquisition +19,676 $29.55 19,676
13 Apr 2026 Carole Ho Former Independent Director Intent to Sell (Form 144) -87,784 $30.73 –
1 Apr 2026 Christine Bellon Chief Legal Officer Intent to Sell (Form 144) -20,000 $21.90 –
1 Apr 2026 John Evans Chief Executive Officer Intent to Sell (Form 144) -66,874 $21.90 –

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 26,082,937 25.3% 13.7
15 Oct 2026 26,243,605 25.4% 14.1
30 Sep 2026 27,548,815 26.7% 15.3
15 Sep 2026 25,884,796 25.1% 12.6
31 Aug 2026 25,802,667 25.0% 14.8
14 Aug 2026 24,374,054 23.6% 16.1

Discussion

No comments yet — be the first to weigh in on BEAM.

Sign in to join the discussion.

Scroll to Top